SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001439222-17-000007
Filing Date
2017-08-08
Accepted
2017-08-08 13:47:23
Documents
64
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q agio-0630x17x10q.htm 10-Q 1108467
2 EXHIBIT 31.1 exhibit31-1x06x30x2017.htm EX-31.1 12457
3 EXHIBIT 31.2 exhibit31-2x06x30x2017.htm EX-31.2 12366
4 EXHIBIT 32.1 exhibit32-1x06x30x2017.htm EX-32.1 6212
5 EXHIBIT 32.2 exhibit32-2x06x30x2017.htm EX-32.2 6169
  Complete submission text file 0001439222-17-000007.txt   5269202

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT agio-20170630.xml EX-101.INS 1086876
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agio-20170630.xsd EX-101.SCH 45670
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agio-20170630_cal.xml EX-101.CAL 53406
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agio-20170630_def.xml EX-101.DEF 229389
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agio-20170630_lab.xml EX-101.LAB 481351
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agio-20170630_pre.xml EX-101.PRE 348517
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS INC (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36014 | Film No.: 171014141
SIC: 2834 Pharmaceutical Preparations